This weekend, we engaged with healthcare professionals nationwide through our Hybrid Treatment and Arrhythmia Management courses. The Hybrid course explored the benefits of Hybrid AF™ Convergent Therapy with EPs and cardiac surgeons, while the Arrhythmia course focused on the importance of surgical treatment for patients and the available options. Thank you to those who joined!

Interested in attending a future course? Visit <a href="https://okt.to/5OB8Dd&quot; target="_blank">https://okt.to/5OB8Dd</a&gt; to learn more and request attendance.
<a href='https://www.linkedin.com/feed/hashtag/?keywords=MedEd&highlightedUpdate…; target='_blank'>#MedEd</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a>

This weekend, we engaged with HCPs in our Hybrid Treatment and Arrhythmia Management courses. We covered the benefits of Hybrid AF™ Convergent Therapy and explored Afib treatment options in depth. Thanks to all who participated!

Learn more about our course offerings:… <a href="https://t.co/KQn0Aj53FD&quot; target="_blank">https://t.co/KQn0Aj53FD</a&gt;

Are you a Medical Device Sales professional in the cardiac space looking to join a growing, global organization? ​
​
AtriCure is expanding our sales team across the globe, and we are looking for driven professionals with a passion in helping patients to join the team. ​
​
Find an opening near you by visiting:​
<a href="https://okt.to/2n3f8w&quot; target="_blank">https://okt.to/2n3f8w</a&gt;

For Dave, living with Afib frequently impacted his day-to-day life. After Hybrid AF™ Therapy, Dave is now back to his normal activities.​
​
Discover how Hybrid AF™ Therapy can positively impact the lives of your LSPAF patients at: <a href="https://t.co/Q6M730FP5H&quot; target="_blank">https://t.co/Q6M730FP5H</a&gt; ​<a href="https://twitter.com/hashtag/Afibawarenessmonth?src=hashtag_click&quot; target="_blank">#Afibawarenessmonth</a>

For Dave, living with Afib frequently impacted his day-to-day life. After Hybrid AF™ Therapy, Dave is now back to his normal activities, and we recently caught up with him at the Cincinnati Museum opening where his story is featured.

Discover how Hybrid AF™ Therapy can positively impact the lives of your long-standing persistent Afib patients at: <a href="https://okt.to/Ss2vAO&quot; target="_blank">https://okt.to/Ss2vAO</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=AfibAwarenessMonth&high…; target='_blank'>#AfibAwarenessMonth</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=AfibAwareness&highlight…; target='_blank'>#AfibAwareness</a>

AtriCure proudly supports the Cincinnati Museum Center's outreach programs and most recently showcased career opportunities in the Medical Device field to help prepare students for success in high school and beyond! With bright futures ahead, we’re confident they’ll achieve great things.

Achieve greater control with the EPi-Sense ST™ device. This technology offers targeted lesion placement with consistent tissue contact, leading to complete lesions.​
​
Learn more about the features and benefits of EPi-Sense here: <a href="https://t.co/okCvFWW3xo&quot; target="_blank">https://t.co/okCvFWW3xo</a&gt;
<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Doing the right thing with the right people leads to better patient care. That was clear as we celebrated being named one of Fast Company’s 2024 Best Workplaces for Innovators, and we’re especially proud to have won in the Women Innovators category! <a href="https://t.co/23jneDkLmc&quot; target="_blank">https://t.co/23jneDkLmc</a&gt;

Achieve greater control with the EPi-Sense ST™ device. This technology offers targeted lesion placement with consistent tissue contact, leading to complete lesions.​
​
Learn more about the features and benefits of EPi-Sense here: <a href="https://okt.to/phFr4i&quot; target="_blank">https://okt.to/phFr4i</a&gt;

Atrial cardiomyopathy (ACM) is a key independent predictor of stroke. The LeAAPS Trial integrates ACM factors to identify high-risk cardiac surgery patients who may benefit from preventative left atrial appendage exclusion.​

Learn more about the trial: <a href="https://t.co/W9PV0ZGzG3&quot; target="_blank">https://t.co/W9PV0ZGzG3</a&gt;… <a href="https://t.co/P83vgNNwW6&quot; target="_blank">https://t.co/P83vgNNwW6</a&gt;